Top

Archives of Gynecology and Obstetrics

Published in:

01-07-2011 | Reproductive Medicine

HIV-infection and modern antiretroviral therapy impair sperm quality

Authors: Sven Kehl, Michael Weigel, Daniel Müller, Monika Gentili, Amadeus Hornemann, Marc Sütterlin

Published in: Archives of Gynecology and Obstetrics | Issue 1/2011

Abstract

Purpose

Serodiscordant couples with a human immunodeficiency virus type 1 (HIV-1)-infected man request assisted reproductive technology (ART) in order to achieve safe conception. Most of these men are on highly active antiretroviral therapy (HAART). HIV-1 infection and the antiretroviral drugs are blamed for semen alterations. The aim of our study was to investigate the semen parameters in HIV-1-infected patients with and without HAART and to compare their sperm characteristics with those of healthy men.

Materials and methods

A prospective study of 226 men attended the university fertility center of Mannheim between May 1996 and July 2003. The patients were divided into three groups: HIV-infected men taking antiretroviral therapy, HIV-infected patients who did not take antiretroviral therapy until now and a control group with 93 men consulting our fertility center together with their wives because of tubal sterility. Semen samples were examined with regard to ejaculate volume, sperm concentration, motility, and morphology.

Results

The study showed significant differences between the ejaculate of HIV-infected and non-infected men. The HIV-infected men as a whole group and the subgroup of men with HAART had a lower ejaculate volume, less slow progressive and more abnormally shaped spermatozoa compared with the control group. The HIV-infected men without an antiretroviral therapy had a significant lower ejaculate volume compared with the control group; the other parameters were not altered significantly. Differences between the subgroups with and without HAART were not significant.

Conclusion

The spermiogram in HIV-1-infected men in comparison to a control group of healthy men is negatively altered. Especially in men with HAART, ejaculate volume as well as sperm morphology and motility changed significantly.

Reshi P, Lone IM Human immunodeficiency virus and pregnancy. Arch Gynecol Obstet 281(5):781–792 doi:10.1007/s00404-009-1334-3

Frodsham LC, Boag F, Barton S, Gilling-Smith C (2006) Human immunodeficiency virus infection and fertility care in the United Kingdom: demand and supply. Fertil Steril 85(2):285–289. doi:10.1016/j.fertnstert.2005.07.1326 PubMedCrossRef

Sherr L, Barry N (2004) Fatherhood and HIV-positive heterosexual men. HIV Med 5(4):258–263. doi:10.1111/j.1468-1293.2004.00218.x PubMedCrossRef

Chu MC, Pena JE, Nakhuda GS, Thornton MH 2nd, Sauer MV (2006) Assessing the reproductive performance of men co-infected with HIV-1 and hepatitis C undergoing assisted reproduction. Arch Gynecol Obstet 274(3):155–159. doi:10.1007/s00404-006-0164-9 PubMedCrossRef

Gupta P, Mellors J, Kingsley L, Riddler S, Singh MK, Schreiber S, Cronin M, Rinaldo CR (1997) High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol 71(8):6271–6275PubMed

Dulioust E, Tachet A, De Almeida M, Finkielsztejn L, Rivalland S, Salmon D, Sicard D, Rouzioux C, Jouannet P (1998) Detection of HIV-1 in seminal plasma and seminal cells of HIV-1 seropositive men. J Reprod Immunol 41(1–2):27–40. S0165-0378(98)00047-3 [pii]PubMedCrossRef

Barroso PF, Schechter M, Gupta P, Melo MF, Vieira M, Murta FC, Souza Y, Harrison LH (2000) Effect of antiretroviral therapy on HIV shedding in semen. Ann Intern Med 133(4):280–284. doi:200008150-00012 PubMed

Taylor S, Ferguson NM, Cane PA, Anderson RM, Pillay D (2001) Dynamics of seminal plasma HIV-1 decline after antiretroviral treatment. AIDS 15(3):424–426PubMedCrossRef

Leruez-Ville M, de Almeida M, Tachet A, Dulioust E, Guibert J, Mandelbrot L, Salmon D, Jouannet P, Rouzioux C (2002) Assisted reproduction in HIV-1-serodifferent couples: the need for viral validation of processed semen. AIDS 16(17):2267–2273PubMedCrossRef

10.

Bujan L, Daudin M, Matsuda T, Righi L, Thauvin L, Berges L, Izopet J, Berrebi A, Massip P, Pasquier C (2004) Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS 18(5):757–766. 00002030-200403260-00006 [pii]PubMedCrossRef

11.

Gupta P, Leroux C, Patterson BK, Kingsley L, Rinaldo C, Ding M, Chen Y, Kulka K, Buchanan W, McKeon B, Montelaro R (2000) Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral Quasi species between blood and semen. J Infect Dis 182(1):79–87. doi:10.1086/315644 PubMedCrossRef

12.

Zhang H, Dornadula G, Beumont M, Livornese L Jr, Van Uitert B, Henning K, Pomerantz RJ (1998) Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 339(25):1803–1809. doi:10.1056/nejm199812173392502 PubMedCrossRef

13.

Dornadula G, Zhang H, VanUitert B, Stern J, Livornese L Jr, Ingerman MJ, Witek J, Kedanis RJ, Natkin J, DeSimone J, Pomerantz RJ (1999) Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy. JAMA 282(17):1627–1632. joc91532 [pii]PubMedCrossRef

14.

Semprini AE (1993) Insemination of HIV-negative women with processed semen of HIV-positive partners. Lancet 341(8856):1343–1344PubMedCrossRef

15.

Marina S, Marina F, Alcolea R, Expósito R, Huguet J, Nadal J, Vergés A (1998) Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination. Fertil Steril 70(1):35–39. S0015-0282(98)00102-2 [pii]PubMedCrossRef

16.

Bujan L, Pasquier C, Labeyrie E, Lanusse-Crousse P, Morucci M, Daudin M (2004) Insemination with isolated and virologically tested spermatozoa is a safe way for human immunodeficiency type 1 virus-serodiscordant couples with an infected male partner to have a child. Fertil Steril 82(4):857–862. doi:10.1016/j.fertnstert.2004.02.128 PubMedCrossRef

17.

Garrido N, Meseguer M, Simon C, Pellicer A, Remohi J (2004) Assisted reproduction in HIV and HCV infected men of serodiscordant couples. Arch Androl 50(2):105–111. L08VW6L2GRQWQGMV [pii]PubMed

18.

Nicopoullos JD, Almeida PA, Ramsay JW, Gilling-Smith C (2004) The effect of human immunodeficiency virus on sperm parameters and the outcome of intrauterine insemination following sperm washing. Hum Reprod 19(10):2289–2297. doi:10.1093/humrep/deh426 PubMedCrossRef

19.

Moyle G (2004) Mitochondrial toxicity: myths and facts. J HIV Ther 9(2):45–47PubMed

20.

Crittenden JA, Handelsman DJ, Stewart GJ (1992) Semen analysis in human immunodeficiency virus infection. Fertil Steril 57(6):1294–1299PubMed

21.

Dondero F, Rossi T, D’Offizi G, Mazzilli F, Rosso R, Sarandrea N, Pinter E, Aiuti F (1996) Semen analysis in HIV seropositive men and in subjects at high risk for HIV infection. Hum Reprod 11(4):765–768PubMed

22.

Dulioust E, Du AL, Costagliola D, Guibert J, Kunstmann JM, Heard I, Juillard JC, Salmon D, Leruez-Ville M, Mandelbrot L, Rouzioux C, Sicard D, Zorn JR, Jouannet P, De Almeida M (2002) Semen alterations in HIV-1 infected men. Hum Reprod 17(8):2112–2118PubMedCrossRef

23.

Muller CH, Coombs RW, Krieger JN (1998) Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1-seropositive men. Andrologia 30(Suppl 1):15–22PubMed

24.

Krieger JN, Coombs RW, Collier AC, Koehler JK, Ross SO, Chaloupka K, Murphy VL, Corey L (1991) Fertility parameters in men infected with human immunodeficiency virus. J Infect Dis 164(3):464–469PubMedCrossRef

25.

Brinkman K, ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP (1998) Adverse effects of reverse transcriptase inhibitors: mitochondrial toxicity as common pathway. AIDS 12(14):1735–1744PubMedCrossRef

26.

Carr A, Miller J, Law M, Cooper DA (2000) A syndrome of lipoatrophy, lactic acidemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 14(3):F25–F32PubMedCrossRef

27.

Bujan L, Sergerie M, Moinard N, Martinet S, Porte L, Massip P, Pasquier C, Daudin M (2007) Decreased semen volume and spermatozoa motility in HIV-1-infected patients under antiretroviral treatment. J Androl 28(3):444–452. doi:10.2164/jandrol.106.001529 CrossRef

28.

Garrido N, Meseguer M, Remohí J, Simón C, Pellicer A (2005) Semen characteristics in human immunodeficiency virus (HIV)- and hepatitis C (HCV)-seropositive males: predictors of the success of viral removal after sperm washing. Hum Reprod 20(4):1028–1034. doi:deh699[pii]10.1093/humrep/deh699 PubMedCrossRef

29.

van Leeuwen E, Wit FW, Prins JM, Reiss P, van der Veen F, Repping S (2008) Semen quality remains stable during 96 weeks of untreated human immunodeficiency virus-1 infection. Fertil Steril 90(3):636–641. doi:10.1016/j.fertnstert.2007.06.102 PubMedCrossRef

30.

van Leeuwen E, Wit FW, Repping S, Eeftinck Schattenkerk JK, Reiss P, van der Veen F, Prins JM (2008) Effects of antiretroviral therapy on semen quality. AIDS 22(5):637–642. doi:10.1097/QAD.0b013e3282f4de10 PubMedCrossRef

31.

Coombs RW, Lockhart D, Ross SO, Deutsch L, Dragavon J, Diem K, Hooton TM, Collier AC, Corey L, Krieger JN (2006) Lower genitourinary tract sources of seminal HIV. J Acquir Immune Defic Syndr 41(4):430–438. doi:10.1097/01.qai.0000209895.82255.08 PubMedCrossRef

32.

Robbins WA, Witt KL, Haseman JK, Dunson DB, Troiani L, Cohen MS, Hamilton CD, Perreault SD, Libbus B, Beyler SA, Raburn DJ, Tedder ST, Shelby MD, Bishop JB (2001) Antiretroviral therapy effects on genetic and morphologic end points in lymphocytes and sperm of men with human immunodeficiency virus infection. J Infect Dis 184(2):127–135. doi:10.1086/322002 PubMedCrossRef

33.

Folgerø T, Bertheussen K, Lindal S, Torbergsen T, Oian P (1993) Mitochondrial disease and reduced sperm motility. Hum Reprod 8(11):1863–1868PubMed

34.

Ruiz-Pesini E, Diez C, Lapeña AC, Pérez-Martos A, Montoya J, Alvarez E, Arenas J, López-Pérez MJ (1998) Correlation of sperm motility with mitochondrial enzymatic activities. Clin Chem 44(8 Pt 1):1616–1620PubMed

35.

May-Panloup P, Chrétien MF, Savagner F, Vasseur C, Jean M, Malthièry Y, Reynier P (2003) Increased sperm mitochondrial DNA content in male infertility. Hum Reprod 18(3):550–556PubMedCrossRef

36.

Johns DR (1995) Seminars in medicine of the Beth Israel Hospital, Boston. Mitochondrial DNA and disease. N Engl J Med 333(10):638–644. doi:10.1056/nejm199509073331007 PubMedCrossRef

37.

Lewis W, Dalakas MC (1995) Mitochondrial toxicity of antiviral drugs. Nat Med 1(5):417–422PubMedCrossRef

38.

Brinkman K, Smeitink JA, Romijn JA, Reiss P (1999) Mitochondrial toxicity induced by nucleoside-analogue reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354(9184):1112–1115. doi:10.1016/S0140-6736(99)06102-4 PubMedCrossRef

39.

Casula M, Weverling GJ, Wit FW, Timmermans EC, Stek M Jr, Lange JM, Reiss P (2005) Mitochondrial DNA and RNA increase in peripheral blood mononuclear cells from HIV-1-infected patients randomized to receive stavudine-containing or stavudine-sparing combination therapy. J Infect Dis 192(10):1794–1800. doi:10.1086/497140 PubMedCrossRef

40.

Phenix BN, Angel JB, Mandy F, Kravcik S, Parato K, Chambers KA, Gallicano K, Hawley-Foss N, Cassol S, Cameron DW, Badley AD (2000) Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. AIDS Res Hum Retroviruses 16(6):559–567. doi:10.1089/088922200308972 PubMedCrossRef

41.

Sloand EM, Kumar PN, Kim S, Chaudhuri A, Weichold FF, Young NS (1999) Human immunodeficiency virus type 1 protease inhibitor modulates activation of peripheral blood CD4(+) T cells and decreases their susceptibility to apoptosis in vitro and in vivo. Blood 94(3):1021–1027PubMed

Title: HIV-infection and modern antiretroviral therapy impair sperm quality
Authors: Sven Kehl
Michael Weigel
Daniel Müller
Monika Gentili
Amadeus Hornemann
Marc Sütterlin
Publication date: 01-07-2011
Publisher: Springer-Verlag
Published in: Archives of Gynecology and Obstetrics / Issue 1/2011
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-011-1898-6

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

HIV-infection and modern antiretroviral therapy impair sperm quality

Abstract

Purpose

Materials and methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Materials and methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2011

Assessment of placental blood flow between 22 and 34 weeks of gestation by 3D-sonography power Doppler vascular indices

A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis

Factors associated with recurrence of cervical intraepithelial neoplasia after conization in HIV-infected and noninfected women

Erratum to: Bone mineral density changes in pregnancies with gestational hypertension: a longitudinal study using quantitative ultrasound measurements

Quality of life and toxicity in breast cancer patients using adjuvant TAC (docetaxel, doxorubicin, cyclophosphamide), in comparison with FAC (doxorubicin, cyclophosphamide, 5-fluorouracil)

High expressions of bcl-2 and survivin, and decreased apoptosis in uterine cervical carcinosarcoma compared to cervical squamous cell carcinoma